For example: Apple Inc, UTIL, Aluminum
Aclaris Therapeutics Inc
NASDAQ:ACRS
Market Close 03/05
21.31 USD +0.17 (+0.80%)
OPEN:
21.36
DAY RANGE:
19.85 - 21.90
PE:
-0.53
PB:
1.41
PS:
5.58
WTD % -4.35
MTD % -4.35
QTD % 229.37
YTD % 229.37
* Updated at market close
Aclaris Therapeutics Inc (NASDAQ:ACRS) opened on Mar 5, 2021 at 21.36 USD and went marginally up by 0.80%. The intraday price range was 19.85 - 21.90 USD and eventually ended the session at 21.31 USD. The stock trade volume was 605,800.00 shares. The company's 52-week range is 0.70 - 25.48 USD.
Trading Statistics (Market Close Mar 5, 2021)
Market Cap 914.61 M
Outstanding Stock 40.94 M
Dividend 0.00
Dividend Yield 0.00
EPS -4.17
YTD Change 229.37%
52 Week's Range 0.70 - 25.48
Key Ratio & Margins (Market Close Mar 5, 2021)
Price/Earning -0.53
Price/Book Value 1.41
Price/Sales 5.58
ROA -
ROE -
Debt/Equity 0.58
Company Self Description
Aclaris Therapeutics, Inc.focuses on identifying, developing, and commercializing various therapies to address the unmet needs in medical and aesthetic dermatology and immunology in the United States. The company operates in two segments, Dermatology Therapeutics and Contract Research. It was founded in 2012 and is headquartered in Wayne, Pennsylvania, United States.
Business Information
Aclaris Therapeutics Inc
Sector Health Care
Industry Pharmaceuticals
Exchange NASDAQ
Top Competitors (Market Close Mar 5, 2021)
  ACRS AERI AMPH PAHC
Daily Change (%) 0.80 -2.60 1.80 -0.92
WTD (%) -4.35 1.96 -0.06 4.87
MTD (%) -4.35 1.96 -0.06 4.87
QTD (%) 229.37 38.79 -12.88 16.48
YTD (%) 229.37 38.79 -12.88 16.48
52-Week Change (%) 1,753.04 11.01 11.52 -13.83
Stock Performance (Market Close Mar 5, 2021)
  ACRS AERI AMPH PAHC
Daily Change (%) 0.80 -2.60 1.80 -0.92
WTD (%) -4.35 1.96 -0.06 4.87
MTD (%) -4.35 1.96 -0.06 4.87
QTD (%) 229.37 38.79 -12.88 16.48
YTD (%) 229.37 38.79 -12.88 16.48
52-Week Change (%) 1,753.04 11.01 11.52 -13.83
Key Fundamentals (Market Close Mar 5, 2021)
  ACRS AERI AMPH PAHC
Market Cap 914.61 M 877.78 M 831.95 M 915.06 M
Revenue Growth - - - -
Net Income Growth - - - -
Profit Margin -979.60% -478.80% 16.30% 8.10%
P/E Ratio -0.53 -5.72 18.85 19.64
Price to Sales Ratio 5.58 27.69 3.07 1.60
Price to Book Ratio 1.41 7.20 2.76 10.04
Enterprise Value to EBITDA -2.11 -6.11 155.28 16.83
ROA - -85.00% 9.90% 9.90%
ROE - -109.90% 15.40% 34.20%
Debt/Equity 0.58 0.25 0.45 2.63
Asset Turnover Ratio 0.07 0.18 0.61 1.21
Current Ratio 6.57 4.34 2.06 2.90
Dividend Yield 0.00 0 0 1.30%
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Revenue 10.09 M 1.68 M 0.00 0.00
Cost Of Revenue 6.85 M 1.21 M 0.00 0.00
Gross Profit 3.24 M 476,000.00 0.00 0.00
Selling General & Administrative Expenses 75.65 M 33.11 M 15.09 M 5.33 M
Research & Development 63.01 M 39.79 M 33.48 M 15.34 M
Operating Income -135.41 M -72.42 M -48.57 M -20.67 M
Net Income -132.74 M -68.52 M -48.08 M -20.56 M
EPS -4.03 -2.44 -2.25 -3.79
Diluted EPS -4.03 -2.44 -2.25 -3.79
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Revenue 5.87 M 5.04 M 3.67 M 1.63 M
Cost Of Revenue 2.70 M 2.78 M 3.51 M 1.19 M
Gross Profit 3.16 M 2.26 M 160,000.00 435,000.00
Selling General & Administrative Expenses 15.17 M 18.02 M 19.66 M 17.95 M
Research & Development 17.62 M 19.92 M 19.54 M 15.93 M
Operating Income -49.79 M -37.34 M -39.04 M -33.45 M
Net Income -49.88 M -37.57 M -38.55 M -32.74 M
EPS -1.21 -0.91 -0.99 -1.06
Diluted EPS -1.21 -0.91 -0.99 -1.06
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Total Current Assets 179.50 M 200.22 M 138.56 M 86.52 M
Cash & Cash Equivalents 57.02 M 20.20 M 30.17 M 9.85 M
Total Assets 275.57 M 243.51 M 176.09 M 94.08 M
Total Current Liabilities 27.34 M 12.76 M 6.22 M 1.56 M
Total Liabilities 60.44 M 18.25 M 6.60 M 1.56 M
Shareholder's Equity 215.12 M 225.26 M 169.49 M 92.52 M
Outstanding Stock 40.94 M 30.83 M 21.43 M 20.16 M
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Total Current Assets 137.89 M 156.81 M 179.50 M 145.52 M
Cash & Cash Equivalents 31.65 M 34.20 M 57.02 M 26.59 M
Total Assets 217.24 M 253.18 M 275.57 M 176.18 M
Total Current Liabilities 42.75 M 36.23 M 27.34 M 22.28 M
Total Liabilities 80.01 M 70.93 M 60.44 M 29.85 M
Shareholder's Equity 137.23 M 182.25 M 215.12 M 146.33 M
Outstanding Stock 41.27 M 41.27 M 40.94 M 30.98 M
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Net Cash Flow from Operations -100.81 M -54.66 M -34.60 M -20.37 M
Capital Expenditures -1.36 M -1.24 M -232,000.00 -507,000.00
Net Cash Flow from Investing Activities 9.37 M -55.69 M -61.90 M -76.95 M
Net Cash Flow from Financial Activities 128.26 M 100.39 M 116.83 M 96.41 M
Free Cash Flow -102.17 M -55.90 M -34.84 M -20.88 M
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Net Cash Flow from Operations -21.38 M -54.66 M -34.60 M -20.37 M
Capital Expenditures -241,000.00 -284,000.00 -146,000.00 -560,000.00
Net Cash Flow from Investing Activities 18.95 M 8.62 M -70.51 M 10.39 M
Net Cash Flow from Financial Activities -117,000.00 -120,000.00 128.18 M 19,000.00
Free Cash Flow -21.62 M -31.60 M -27.39 M -30.42 M
Key Ratios (Market Close Mar 5, 2021)
Valuation Ratios 2021 2020 2019 2018
P/E Ratio -0.53 -1.51 -1.83 -3.81
Price to Sales Ratio 5.58 17.63 24.10 60.62
Price to Book Ratio 1.41 3.38 3.43 5.87
Enterprise Value to EBIT -2.00 -10.00 -12.00 -25.00
Enterprise Value to EBITDA -2.11 -10.01 -11.76 -25.28
Profitability Ratios 2021 2020 2019 2018
Revenue Growth - - - -
Net Income Growth - - - -
ROA - - - -60.70%
ROE - - - -72.10%
Liquidity Ratios 2021 2020 2019 2018
Working Capital 152.16 M 187.46 M 132.33 M 84.97 M
Current Ratio 6.57 15.69 22.27 55.64
Efficiency & Capital Structure Ratios 2021 2020 2019 2018
Debt Equity Ratio 0.58 0.08 0.04 0.02
Asset Turnover Ratio - - - 0.05
Scratchpad (max of 30 tickers)
Symbol Last Price Change
Empty Scratchpad
Portfolio (max of 30 tickers)
Login is required to view your portfolio.